Atlas Trials

Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer

Clinical trial NCT01010854 · TERMINATED

Trial details

NCT number
NCT01010854
Sponsor
University of California, San Francisco
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2008-12-10
Primary completion
2010-12-12
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.